Implementing findings of medical research: the Cochrane Collaboration on Effective Professional Practice.

The availability of high quality systematic reviews of interventions is essential for providers and purchasers if they are to make sense of the ever increasing volume of medical research. The aim of the recently formed Cochrane Collaboration on Effective Professional Practice is to undertake and maintain systematic reviews of rigorous research which evaluate methods of promoting effective professional practice and to make these reviews available to relevant decision makers. The focus of this group is on reviews of trials of interventions designed to improve professional practice, including, for example, various forms of information dissemination, continuing education, and quality assurance. providers and collaboration reviewers The and

[1]  F. Mosteller,et al.  A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.

[2]  T C Chalmers,et al.  Getting to grips with Archie Cochrane's agenda. , 1992, BMJ.

[3]  J M Grimshaw,et al.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. , 1994, Lancet.

[4]  J. Grimshaw,et al.  Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations , 1993, The Lancet.

[5]  G. Feder.  Management of mild hypertension: Which guidelenes to follow? , 1994 .

[6]  D M Eddy,et al.  Clinical policies and the quality of clinical practice. , 1982, The New England journal of medicine.

[7]  R. Haynes,et al.  Evidence for the effectiveness of CME. A review of 50 randomized controlled trials. , 1992, JAMA.

[8]  P. Winocour.  Management of mild hypertension: Too little emphasis on metabolic factors , 1994, BMJ.

[9]  K. Dickersin,et al.  Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .

[10]  D. Ketley,et al.  Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction , 1993, The Lancet.

[11]  Walker,et al.  Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients , 1994 .

[12]  C. Mulrow.  The medical review article: state of the science. , 1987, Annals of internal medicine.

[13]  Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy , 1994, BMJ.

[14]  R. Haynes,et al.  Effects of Computer-based Clinical Decision Support Systems on Clinician Performance and Patient Outcome: A Critical Appraisal of Research , 1994, Annals of Internal Medicine.

[15]  F. Akiyama.  [Management of mild hypertension]. , 1966, Nihon Ishikai zasshi. Journal of the Japan Medical Association.

[16]  Radcliffe Infirmary,et al.  Collaborative overview of randomised trials of antiplatelet therapy - III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients , 1994, BMJ.

[17]  A. L. Cochrane,et al.  Effectiveness and efficiency: random reflections on health services , 1972 .

[18]  L. Bolognese,et al.  RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2 , 1988, The Lancet.